Stifel Nicolaus Increases Merus (NASDAQ:MRUS) Price Target to $99.00
Merus (NASDAQ:MRUS – Free Report) had its price target upped by Stifel Nicolaus from $90.00 to $99.00 in a report issued on Monday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the biotechnology company’s stock. Other analysts have also recently issued research reports about the company. Guggenheim lifted their price target on Merus […]
More Stories
Analyzing Mercury General (NYSE:MCY) & Deep Yellow (OTCMKTS:DYLLF)
Volatility & Risk Mercury General has a beta of 0.87, indicating that its stock price is 13% less volatile than...
Analyzing Mercury General (NYSE:MCY) & Deep Yellow (OTCMKTS:DYLLF)
Volatility & Risk Mercury General has a beta of 0.87, indicating that its stock price is 13% less volatile than...
Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research...
Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research...
VR Resources (CVE:VRR) Trading Down 16.7% – Here’s What Happened
VR Resources Ltd. (CVE:VRR – Get Free Report)’s share price traded down 16.7% during trading on Friday . The company...
VR Resources (CVE:VRR) Trading Down 16.7% – Here’s What Happened
VR Resources Ltd. (CVE:VRR – Get Free Report)’s share price traded down 16.7% during trading on Friday . The company...